A photo of Sharat Chandra.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Assistant Professor, UC Department of Pediatrics



Board Certified

About Me

Additional Languages

Hindi, Marathi

Academic Affiliation

Assistant Professor, UC Department of Pediatrics


Cancer and Blood Diseases, Bone Marrow Transplantation BMT, 22Q-VCFS, Immune Deficiencies and Histiocytosis

My Education

MBBS: Andhra Medical College, University of Health Sciences, Visakhapatnam, India.

Residency: Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 1998-2001; University Hospitals of Leicester, South Warwickshire Hospitals NHS, United Kingdom, 2003-2006; University of South Alabama, 2006-2009.

Fellowship: Pediatric Hematology-Oncology, Cincinnati Children’s Hospital Medical Center, 2009-2012.

Certification: MD (Pediatrics), 2001; Royal College of Pediatrics and Child Health (MRCPCH), 2006; Board Certified in General Pediatrics by the American Board of Pediatrics, 2009; Board Certified in Pediatric Hematology-Oncology by the American Board of Pediatrics, 2013.

My Publications

Selected Publication

EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects. Rubinstein, JD; Burns, K; Absalon, M; Lutzko, C; Leemhuis, T; Chandra, S; Hanley, PJ; Keller, MD; Davies, SM; Nelson, A; et al. Pediatric Blood and Cancer. 2020; 67.

Abnormal Newborn Screening Follow-up for Severe Combined Immunodeficiency in an Amish Cohort with Cartilage-Hair Hypoplasia. Scott, EM; Chandra, S; Li, J; Robinette, ED; Brown, MF; Wenger, OK. Journal of Clinical Immunology. 2020; 40:321-328.

The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1). Kellner, ES; Rathbun, PA; Marshall, GS; Tolusso, LK; Smolarek, TA; Sun, M; Chandra, S; Bleesing, J; Marsh, RA. Journal of Clinical Immunology. 2019; 39:857-859.

Primary immune regulatory disorders for the pediatric hematologist and oncologist: A case-based review. Chandrakasan, S; Chandra, S; Saldana, BJ D; Torgerson, TR; Buchbinder, D. Pediatric Blood and Cancer. 2019; 66:e27619-e27619.

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). Dvorak, CC; Haddad, E; Buckley, RH; Cowan, MJ; Logan, B; Griffith, LM; Kohn, DB; Pai, S; Notarangelo, L; Shearer, W; et al. Journal of Allergy and Clinical Immunology. 2019; 143:405-407.

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Haddad, E; Logan, BR; Griffith, LM; Buckley, RH; Parrott, RE; Prockop, SE; Small, TN; Chaisson, J; Dvorak, CC; Mumane, M; et al. Blood. 2018; 132:1737-1749.

Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study. Chandra, S; Fukuda, T; Mizuno, K; Davies, SM; Teusink-Cross, A; Tarin, R; Marsh, RA; Vinks, AA; Mehta, PA. Journal of Antimicrobial Chemotherapy. 2018; 73:1651-1658.

Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation. Mizuno, K; Dong, M; Fukuda, T; Chandra, S; Mehta, PA; McConnell, S; Anaissie, EJ; Vinks, AA. Clinical Pharmacokinetics. 2018; 57:625-636.

Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Silva, JM F; Ladomenou, F; Carpenter, B; Chandra, S; Sedlacek, P; Formankova, R; Grandage, V; Friswell, M; Cant, AJ; Nademi, Z; et al. Blood Advances. 2018; 2:777-786.

Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: A PIDTC natural history study. Heimall, J; Logan, BR; Cowan, MJ; Notarangelo, LD; Griffith, LM; Puck, JM; Kohn, DB; Pulsipher, MA; Parikh, S; Martinez, C; et al. Blood. 2017; 130:2718-2727.